Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:REXR
NYSE:REXRIndustrial REITs

Is It Time To Reassess Rexford Industrial Realty (REXR) After Recent Share Price Recovery?

If you are wondering whether Rexford Industrial Realty at around US$36.33 is offering good value today, the key is to look beyond headline returns and focus on what the current price implies. The stock has returned 1.1% over the last week and 6.9% over the past month, while year to date it is down 6.9% and sits on a 12.8% gain over the last year, with 3 year and 5 year returns at 25.5% and 23.2% declines respectively. Recent coverage has largely centered on how Rexford fits into investor...
NasdaqGS:AGYS
NasdaqGS:AGYSSoftware

Is It Time To Reassess Agilysys (AGYS) After Its Sharp Share Price Pullback?

For investors wondering whether Agilysys at around US$63 a share still offers value or if the easy gains are behind it, this article walks through what the numbers are really saying about the stock. The share price closed at US$63.09, with returns of a 6.7% decline over 7 days, an 11.7% decline over 30 days, a 45.4% decline year to date, and a 14.3% decline over the past year, which may have shifted how the market views its risk and reward trade off. Recent coverage has focused on how this...
NYSE:HXL
NYSE:HXLAerospace & Defense

Hexcel (HXL) Q1 EPS Swings Test Bullish Earnings Growth Narrative

Hexcel (HXL) opened Q1 2026 with revenue of US$501.5 million and basic EPS of US$0.49, setting the tone for how investors are reading the new earnings season. The company has seen quarterly revenue range from US$456.5 million in Q1 2025 to US$491.3 million in Q4 2025, while basic EPS moved between US$0.17 in Q2 2025 and US$0.60 in Q4 2025. This gives a clear view of how the top and bottom lines have tracked into this latest print. With that backdrop, the key question now is whether current...
TSX:BNS
TSX:BNSBanks

Is It Too Late To Consider Bank Of Nova Scotia (TSX:BNS) After 60% One-Year Rally?

If you are wondering whether Bank of Nova Scotia's share price still offers value after a strong run, this breakdown will help you put the current price in context. The stock recently closed at CA$102.72, with returns of 7.4% over 30 days and 60.3% over 1 year, following gains of 81.8% over 3 years and 73.2% over 5 years. Recent headlines around Bank of Nova Scotia have focused on its role within the Canadian banking sector and how larger banks are positioned in the current rate and credit...
NasdaqGM:FUTU
NasdaqGM:FUTUCapital Markets

Futu’s Moomoo API Skills Brings AI Agents To Retail Trading Workflows

Moomoo, owned by Futu Holdings (NasdaqGM:FUTU), has launched "Moomoo API Skills" for retail investors. The new feature lets users connect their own AI agents to automate professional-grade trading without coding expertise. The rollout introduces natural language strategy creation, 24/7 monitoring, and manual trade confirmation directly within the Moomoo platform. Futu Holdings runs Moomoo as a digital brokerage platform focused on self-directed investors who want access to tools once...
NYSE:ATR
NYSE:ATRPackaging

AptarGroup Climate Leader Status Meets Undervalued Stock And ESG Appeal

AptarGroup (NYSE:ATR) has been recognized as one of America’s Climate Leaders for the fourth consecutive year by USA Today. The latest recognition highlights the company’s ongoing efforts around emissions reductions and broader sustainability goals. Repeat accolades from USA Today and the CDP continue to validate AptarGroup’s climate focused initiatives. AptarGroup, trading at around $124.94 per share, is drawing attention for its sustainability profile as much as its role in dispensing and...
ASX:WOW
ASX:WOWConsumer Retailing

Is It Too Late To Consider Woolworths Group (ASX:WOW) After Its Strong Share Price Run?

If you are wondering whether Woolworths Group at A$37.89 is offering good value or just pricing in a lot of optimism, you are not alone. The stock has returned 3.0% over the last week, 4.2% over the past month, 28.7% year to date and 23.6% over the last year, which naturally raises questions about what is already baked into the current price. Recent coverage has focused on Woolworths Group as a core consumer staples name on the ASX, with attention on how shoppers are responding to pricing,...
NasdaqGS:HON
NasdaqGS:HONIndustrials

Honeywell International (HON) Margin Compression Challenges Bullish Earnings Narratives Ahead Of Q1 2026

Honeywell International (HON) has put fresh numbers on the table for Q1 2026, with Q4 2025 revenue at US$9.8 billion and basic EPS of US$0.49 setting the tone for how investors are reading the current US$214.34 share price. Over the recent quarters, the company has seen revenue move from US$9.6 billion in Q2 2024 to US$9.7 billion in Q3 2024 and then to US$9.8 billion in Q4 2025. Quarterly basic EPS shifted from US$2.37 to US$2.17 to US$2.24 and then US$2.46 before the latest Q4 figure,...
NYSE:DCOM
NYSE:DCOMBanks

Dime Community Bancshares (DCOM) Margin Rebound Challenges Longer Term Earnings Decline Narrative

Dime Community Bancshares (DCOM) Q1 2026 results in focus Dime Community Bancshares (DCOM) has just reported its Q1 2026 results with recent quarterly revenue most recently at about US$112.9 million in Q4 2025, basic EPS at US$0.67 and trailing twelve month EPS at US$2.36, set against a very large 373.9% reported earnings growth over the past year. Over the last six reported quarters, revenue has ranged from US$43.5 million in Q4 2024 to US$112.9 million in Q4 2025, while quarterly EPS has...
NYSE:REX
NYSE:REXOil and Gas

A Look At REX American Resources (REX) Valuation After Proposed Authorized Share Increase

Why the share authorization proposal matters for REX American Resources (REX) REX American Resources (REX) plans to ask shareholders on May 28, 2026 to approve an increase in authorized common stock from 45,000,000 to 90,000,000 shares. This type of authorization change can give the company more flexibility for potential future capital raising, stock-based transactions, or corporate actions. This is why it often becomes a focal point for existing and prospective shareholders. See our latest...
NYSE:ARR
NYSE:ARRMortgage REITs

Armour Residential REIT (ARR) Heads Into Q1 2026 With Volatile Revenue And EPS Swings

ARMOUR Residential REIT (ARR) opened its latest earnings season update with investors focused on how its recent results line up with a year of shifting quarterly EPS and revenue, including Q4 2025 revenue of about US$225.7 million and EPS of US$1.86. Over the past six reported quarters, revenue has ranged from a loss of US$61.3 million in Q2 2025 to US$225.7 million in Q4 2025, while EPS has swung between a loss of US$0.94 and a gain of US$1.86. This sets up this quarter’s release as a check...
ENXTAM:LIGHT
ENXTAM:LIGHTElectrical

Is It Time To Reassess Signify (ENXTAM:LIGHT) After Mixed Long Term Share Performance?

If you are wondering whether Signify at around €19.79 is offering value or risk at this point, the recent share performance gives you a starting clue but not the full story. The stock has moved 7.7% over the past 30 days, while returns stand at 11.6% over 1 year but show declines of 8.5% year to date, 20.0% over 3 years and 43.7% over 5 years. Recent news coverage around Signify has focused on the company as a key listed player in lighting and related technologies. This helps explain why the...
NYSE:PHM
NYSE:PHMConsumer Durables

PulteGroup (PHM) Margin Compression To 12.8% Tests Bullish Earnings Narrative

PulteGroup (PHM) has just opened the books on Q1 2026 with investors looking back at recent quarters where quarterly revenue moved from US$4.9b in Q4 2024 to US$4.6b in Q4 2025 and basic EPS shifted from US$4.47 to US$2.58 as net income moved from US$913.2 million to US$501.6 million. Over the same stretch, trailing twelve month revenue moved in a tight band around US$17.3b to US$18.0b while trailing EPS eased from US$14.82 to US$11.21, which sets up this new quarter against a backdrop of...
ENXTPA:RMS
ENXTPA:RMSLuxury

A Look At Hermès (ENXTPA:RMS) Valuation After Q1 2026 Revenue Growth And Currency Headwinds

Q1 2026 revenue snapshot and regional trends Hermès International Société en commandite par actions (ENXTPA:RMS) reported first quarter 2026 consolidated revenue of €4.1b, with 6% growth at constant exchange rates and double digit expansion in the Americas, Japan, and Europe excluding France. Currency movements reduced reported sales by €290 million, leaving revenue down 1% at current exchange rates. This highlights that headline figures can differ from underlying trading conditions for...
NasdaqGS:ACHC
NasdaqGS:ACHCHealthcare

Interim CFO Return Puts Acadia Healthcare Leadership Stability In Focus

Acadia Healthcare Company (NasdaqGS:ACHC) has appointed David Duckworth as Interim CFO, replacing outgoing CFO Todd Young. Duckworth returns to the role after nearly a decade of prior service as Acadia's CFO. The transition occurs while the company continues its search for a permanent CEO. Acadia Healthcare shares recently closed at $27.34, with the stock up 20.5% over the past 30 days and 1.7% over the past week. Over a longer horizon, returns have been mixed, with a 91.3% return year to...
NYSE:WRB
NYSE:WRBInsurance

New Berkley Environmental Leader Puts Focus On Underwriting And Growth Narrative

W. R. Berkley (NYSE:WRB) has appointed R. Christopher DeLauder as president of Berkley Environmental. The move reflects an internal promotion within a key specialty unit focused on environmental insurance. The leadership change signals a new point person for underwriting, risk focus, and execution inside this subsidiary. The appointment at Berkley Environmental comes as W. R. Berkley shares trade around $68.45, with returns of 3.3% over the past week and 5.3% over the past month. Over a...
NYSE:SYF
NYSE:SYFConsumer Finance

Synchrony Financial Expands Into Women’s Apparel With New Loyalty Suite

Synchrony Financial (NYSE:SYF) has rolled out a co-branded credit card and digital loyalty suite with Chico's, White House Black Market, and Soma. The launch introduces a unified rewards ecosystem across the Chico's FAS brands, focused on women's apparel and lifestyle shoppers. The new products use Synchrony’s PRISM credit decisioning technology to support both in store and digital customer experiences. For investors watching NYSE:SYF, this move comes as the shares trade at $76.62, with a 1...
NasdaqGS:CHTR
NasdaqGS:CHTRMedia

Is It Time To Reconsider Charter Communications (CHTR) After Its Recent Share Price Rebound?

If you are wondering whether Charter Communications at around US$241.78 is pricing in too much pessimism or quiet value, the stock's recent history gives you a lot to chew on. The share price has returned 2.5% over the last 7 days and 11.1% over 30 days, while year to date it is up 15.5% but still shows a 27.9% decline over 1 year and a 63.9% decline over 5 years. Recent coverage has focused on how Charter sits within the broader US media space, with investors weighing cable and broadband...
NasdaqGS:CMPS
NasdaqGS:CMPSBiotechs

Has The Surge In COMPASS Pathways (CMPS) Shares Left The Valuation Looking Stretched?

Wondering whether COMPASS Pathways at around US$9.15 still stacks up on value or has run ahead of itself? This article breaks down what the recent moves might mean for you as an investor. The stock has recently shown strong momentum, with returns of 37.4% over 7 days, 75.3% over 30 days, 39.7% year to date and 129.3% over 1 year, while the 3 year return sits at 13.2% and the 5 year return at a loss of 76.5%. These swings have come as COMPASS Pathways continues to sit in the spotlight of...
NasdaqGM:ARDX
NasdaqGM:ARDXBiotechs

Is Ardelyx (ARDX) Pricing Reflecting Its DCF Upside After Recent Share Price Swings

If you are wondering whether Ardelyx at around US$5.96 is priced attractively or not, the key question is how that tag compares with what the business might reasonably be worth. The stock has been volatile recently, with a 5.1% decline over the last 7 days, an 11.4% gain over 30 days, a 3.1% decline year to date, and an 18.7% return over the past year, which may signal changing views on its potential and risk. Recent headlines around Ardelyx have focused on its place in the biotech space and...
TSE:3407
TSE:3407Chemicals

Asahi Kasei Expands Pharma Reach With Aicuris Deal And AK1940 Trial

Asahi Kasei (TSE:3407) has completed its acquisition of German biopharmaceutical company Aicuris Anti-infective Cures. The company has also initiated a Phase I clinical trial for AK1940, a new therapy candidate for autoimmune diseases. Both developments mark a shift in focus toward infectious and autoimmune disease treatments within Asahi Kasei's pharmaceutical operations. Asahi Kasei, traditionally known for chemicals, materials, and health care businesses, is steadily building out its...